TrianglePUBLICATIONS · 29347993
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Immunother Cancer
- Publication date
- 2018 Jan 19
- First author
- Kaufman HL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kaufman HL
- type
- Author
- name
- Russell JS
- type
- Author
- name
- Hamid O
- type
- Author
- name
- Bhatia S
- type
- Author
- name
- Terheyden P
- type
- Author
- name
- D'Angelo SP
- type
- Author
- name
- Shih KC
- type
- Author
- name
- Lebbé C
- type
- Author
- name
- Milella M
- type
- Author
- name
- Brownell I
- type
- Author
- name
- Lewis KD
- type
- Author
- name
- Lorch JH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kaufman HL
- type
- Author
- name
- Russell JS
- type
- Author
- name
- Hamid O
- type
- Author
- name
- Bhatia S
- type
- Author
- name
- Terheyden P
- type
- Author
- name
- D'Angelo SP
- type
- Author
- name
- Shih KC
- type
- Author
- name
- Lebbé C
- type
- Author
- name
- Milella M
- type
- Author
- name
- Brownell I
- type
- Author
- name
- Lewis KD
- type
- Author
- name
- Lorch JH
- type
- Author
- bibliography ids
- nci-bib-915a5092c4d23b16a468e79a
- book metadata
- content sha256
- 388f0b3d47afbfffc27d5168de007424ffc8b719f7f18c07b6b17c5a72630e61
- document type
- citation
- dois
- 10.1186/s40425-017-0310-x
- electronic publication date
- display
- 2018 Jan 19
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29347993
- immutable id
- pubmed:29347993@388f0b3d47afbfffc27d5168de007424ffc8b719f7f18c07b6b17c5a72630e61
- journal
- abbreviation
- J Immunother Cancer
- issn electronic
- 2051-1426
- issn print
- Source null
- issue
- 1
- name
- Journal for immunotherapy of cancer
- nlm unique id
- 101620585
- pages
- 7
- volume
- 6
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29347993
- provenance
- batch id
- ec9444d0f4cade22eb9f
- provider
- NCBI PubMed ESummary
- record sha256
- 011ce4bb71a58037e88621ca19d9764a0bb1f83c5c2bfe7a25062792df3f41c8
- response sha256
- 6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
- retrieved at
- 2026-09-09T23:47:30.975610+00:00
- publication date
- display
- 2018 Jan 19
- precision
- day
- year
- 2018
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
Preserved source evidence · Not medical advice